Search

Your search keyword '"Ritter, Nathan"' showing total 22 results
Start Over Author "Ritter, Nathan"
22 results on '"Ritter, Nathan"'

4. Bone Mineral Density as a Predictor of Cardiovascular Disease in Women: A Real-World Retrospective Study

Author

Renjithlal, Sarath Lal Mannumbeth, primary, Magdi, Mohamed, additional, Mostafa, Mostafa Reda, additional, Renjith, Keerthi, additional, Pillai, Parvathi, additional, Syed, Musaib, additional, Mohamed, Sarah, additional, Zahid, Viqarunnisa, additional, Ritter, Nathan, additional, Al Ali, Omar, additional, Balmer-Swain, Mallory, additional, Makaryus, Amjad, additional, and Pillai, Nisha, additional

Published
2022
Full Text
View/download PDF

5. Ticagrelor use in patients after percutaneous coronary intervention: one year follow up in a community hospital

Author

Mannumbeth Renjithlal, Sarath Lal, Magdi, Mohamed, Renjith, Keerthi, Mostafa, Mostafa Reda, Syed, Musaib, Shaukat, Fahd, Zahid, Viqarunnisa, and Ritter, Nathan

Subjects
Original Article
Abstract

Background: Current guidelines from American College of Cardiology (ACC) recommend ticagrelor over clopidogrel in patients with acute coronary syndrome. We have observed many patients being switched from ticagrelor to clopidogrel after percutaneous coronary intervention (PCI) in our hospital. Our goal is to evaluate the use rate of ticagrelor and categorize the reasons for non-use. Methods: We performed a retrospective data analysis of all patients who underwent PCI at Unity Hospital of Rochester, New York, from January 2019 to January 2020. A total of 330 patients underwent PCI for ACS over the year. After exclusions, 277 patients were enrolled in the analysis. Results: Of the 277 patients, 179 (65%) completed one year of ticagrelor therapy, and 98 (35%) stopped ticagrelor and transitioned to clopidogrel. The most common reason for switching from ticagrelor was dyspnea (42 patients), followed by cost concerns (41 patients). Conclusion: At our community hospital, completion of one-year use of ticagrelor post-PCI occurred in 65% of patients. The most common reasons for discontinuation are dyspnea and medication cost.

Published
2022

12. Is obstructive sleep apnea associated with ventricular tachycardia? A retrospective study from the National Inpatient Sample and a literature review on the pathogenesis of Obstructive Sleep Apnea

Author

Salama, Amr, primary, Abdullah, Abdullah, additional, Wahab, Abdul, additional, Eigbire, George, additional, Hoefen, Ryan, additional, Kouides, Ruth, additional, Ritter, Nathan, additional, Mieszczanska, Hanna, additional, and Alweis, Richard, additional

Published
2018
Full Text
View/download PDF

21. Ticagrelor use in patients after percutaneous coronary intervention: one year follow up in a community hospital.

Author

Mannumbeth Renjithlal SL, Magdi M, Renjith K, Mostafa MR, Syed M, Shaukat F, Zahid V, and Ritter N

Abstract

Background: Current guidelines from American College of Cardiology (ACC) recommend ticagrelor over clopidogrel in patients with acute coronary syndrome. We have observed many patients being switched from ticagrelor to clopidogrel after percutaneous coronary intervention (PCI) in our hospital. Our goal is to evaluate the use rate of ticagrelor and categorize the reasons for non-use., Methods: We performed a retrospective data analysis of all patients who underwent PCI at Unity Hospital of Rochester, New York, from January 2019 to January 2020. A total of 330 patients underwent PCI for ACS over the year. After exclusions, 277 patients were enrolled in the analysis., Results: Of the 277 patients, 179 (65%) completed one year of ticagrelor therapy, and 98 (35%) stopped ticagrelor and transitioned to clopidogrel. The most common reason for switching from ticagrelor was dyspnea (42 patients), followed by cost concerns (41 patients)., Conclusion: At our community hospital, completion of one-year use of ticagrelor post-PCI occurred in 65% of patients. The most common reasons for discontinuation are dyspnea and medication cost., Competing Interests: None., (AJCD Copyright © 2022.)

Published
2022

22. Recurrent Pseudomonas aortic root abscess complicating mitral valve endocarditis.

Author

Aggarwal A, Ritter N, Reddy L, Lingutla D, Nasar F, El-Daher N, and Hsi D

Subjects
Abscess diagnosis, Abscess microbiology, Aortic Diseases diagnosis, Aortic Diseases microbiology, Diagnosis, Differential, Echocardiography, Transesophageal, Endocarditis, Bacterial microbiology, Fatal Outcome, Humans, Male, Middle Aged, Mitral Valve, Pseudomonas Infections diagnosis, Pseudomonas Infections microbiology, Abscess etiology, Aorta, Thoracic, Aortic Diseases etiology, Endocarditis, Bacterial complications, Pseudomonas Infections etiology, Pseudomonas aeruginosa isolation & purification
Abstract

We report on a man with Pseudomonas aeruginosa endocarditis causing an aortic root abscess. He underwent surgery with a homograft aortic root replacement and insertion of a tissue aortic valve. The patient then manifested recurrent aortic root infection and respiratory arrest, and eventually succumbed to sepsis. This case highlights the aggressive nature of an uncommon pathogen causing an atypical but lethal form of endocarditis, despite modern medical and surgical treatment., (Published by Mosby, Inc.)

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results